Navigation Links
Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
Date:12/4/2007

ould not alter anticoagulant management because the effect of withdrawal of anticoagulant therapy during Soliris treatment has not been established.

The U.S. product label for Soliris also includes a boxed warning: "Soliris increases the risk of meningococcal infections. Vaccinate patients with a meningococcal vaccine at least two weeks prior to receiving the first dose of Soliris; revaccinate according to current medical guidelines for vaccine use. Monitor patients for early signs of meningococcal infections, evaluate immediately if infection is suspected, and treat with antibiotics if necessary." During clinical studies, two out of 196 vaccinated PNH patients treated with Soliris experienced a serious meningococcal infection. Prior to beginning Soliris therapy, all patients and their prescribing physicians are enrolled in the Soliris Safety Registry which is part of a special risk management program that involves initial and continuing education and long- term monitoring for detection of new safety findings.

Please see full prescribing information at http://www.soliris.net.

About Alexion

Alexion Pharmaceuticals, Inc. is a biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. The Company is engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with a wide array of severe disease states, including hematologic diseases, cancer, and autoimmune disorders. The Company is evaluating other potential indications for Soliris as well as other formulations of eculizumab for additional clinical indications, and is actively pursuing development of other antibody product candidates in early stages of development. This press release and further information about Alexion Pharmaceuticals, Inc. can be found at: '/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
4. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
5. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
10. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
11. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... April 21, 2015 Workers, compensation pharmacy spending ... decrease in utilization helped offset a 7 percent increase ... released today by Express Scripts (NASDAQ: ESRX ). ... Drug Trend Report discusses the overall pharmacy trend as ... workers. Opioid Management Mitigates Spend Increases ...
(Date:4/21/2015)...  Leadership speaker and business author Mary Kelly, Ph.D ., is helping members of the ... Photo - http://photos.prnewswire.com/prnh/20150420/199849 ... ... ... run a successful medical practice without pulling your hair out of your head or going bankrupt," ...
(Date:4/21/2015)... VIEW, Calif. , April 21, 2015 /PRNewswire/ ... and healthcare reforms the market for self-monitoring blood ... several challenges limit the revenue potential for this ... intensified competition and strained participants, profit margins. ... New analysis from Frost & Sullivan, ...
Breaking Medicine Technology:Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs 2Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs 3Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs 4Medical Group Managers Build Effective Practices with Strategies from Leadership Expert Mary Kelly 2Medical Group Managers Build Effective Practices with Strategies from Leadership Expert Mary Kelly 3Medical Group Managers Build Effective Practices with Strategies from Leadership Expert Mary Kelly 4Medical Group Managers Build Effective Practices with Strategies from Leadership Expert Mary Kelly 5Noninvasive Glucose Monitors Creates Convergence with the Digital Health Era 2Noninvasive Glucose Monitors Creates Convergence with the Digital Health Era 3Noninvasive Glucose Monitors Creates Convergence with the Digital Health Era 4
... Turkey, June 13 Disc Motion Technologies,announced the ... the,True Total Spinal Motion Segment System (TM) (TSMS(TM)), ... spine, featuring an artificial,lumbar disc and posterior dynamic ... May 22nd, 2008 at Ankara Numune,Education and Training ...
... of BCR-ABL That Cause Resistance to Current ... CML and ... EXEL ) today reported preliminary phase 1 data from an ongoing,trial ... acute lymphocytic leukemia (Ph+ALL) who,are resistant to or intolerant of the ...
Cached Medicine Technology:Disc Motion Technologies Announces First Human Implants of True TSMS(TM) Device 2Exelixis Presents Clinical Data Supporting the Safety and Initial Clinical Activity of XL228 in Chronic and Acute Leukemia 2Exelixis Presents Clinical Data Supporting the Safety and Initial Clinical Activity of XL228 in Chronic and Acute Leukemia 3Exelixis Presents Clinical Data Supporting the Safety and Initial Clinical Activity of XL228 in Chronic and Acute Leukemia 4
(Date:4/21/2015)... Autocarsinsurancetips.com has released a new blog post explaining how ... by comparing quotes. , Comparing online auto insurance ... their neighborhood. The insurance market is highly competitive and ... comparing different plans. , Clients can compare vehicle ... brokerage websites like http://autocarsinsurancetips.com/ provide free information ...
(Date:4/21/2015)... 21, 2015 Carinsurancesavings.biz has released a new ... proper surveillance and explaining the impact on a uto ... safe and supervised may be eligible for advantageous auto insurance ... a simple and efficient way. This will also help them ... and simple way. , Finding low cost coverage is no ...
(Date:4/21/2015)... LifeWings Partners LLC today announced a toolkit ... their safety programs by getting more support from their ... proven ways to get more physician support and engagement ... Care Act, the new model of health care reimbursement ... the volume of services. Health care leaders feel an ...
(Date:4/21/2015)... 21, 2015 When a bandage sticks ... result. In order to solve this problem two inventors ... , This improved bandage helps a cut, burn, abrasion ... and enhances air exposure. The bandage is easy to ... original design was submitted to the St. Louis office ...
(Date:4/21/2015)... 21, 2015 A new study at ... patients with peritoneal cancers like mesothelioma increased by 20 ... just posted the results of the study. Click ... Doctors at North Hampshire Hospital in Basingstoke performed a ... malignancies such as mesothelioma between 1994 and 2014. ...
Breaking Medicine News(10 mins):Health News:Online Auto Insurance Quotes Can Help Clients Save Money 2Health News:Auto Insurance Quotes Offer Excellent Security for A Car 2Health News:LifeWings Announces New Physician Engagement Toolkit to Help Hospitals Weather Serious Ramifications of the Affordable Care Act 2Health News:New Findings Highlight Value of Experience in Peritoneal Mesothelioma Treatment, According to Surviving Mesothelioma 2
... the release of interleukin-8 (IL-8) from gastric epithelia, which initiates ... in the pathogenesis of H. pylori infections. ... major initiator in H. pylori -induced IL-8 production via ... Considering the novel finding that H. pylori is ...
... Valley residents,neuroscience researchers, and interested clinicians will each ... the,topic of stroke during the Texas Brain and ... This year,s symposium will consist of a,morning presentation ... clinicians,and researchers. The speakers are both neuroscience specialists ...
... Gilson & Lione, one of,the largest intellectual property law ... Cheung-Ka Ong has joined the firm,s Salt Lake City,Utah ... received a B.S. in neuroscience from Brigham Young,University and ... Diego, La Jolla. He received his J.D. from the ...
... on chromosome 15 contains genetic variations strongly associated with ... at Washington University School of Medicine in St. Louis ... United Kingdom. , The researchers found a more than ... who have both a family history of the disease ...
... in tandem with clot-dissolving drug , , TUESDAY, Sept. 9 ... drug tPA to people with very high blood pressure ... indicates. , The American Heart Association recently updated its ... plasminogen activator, in such cases, "but there was no ...
... WASHINGTON, Sept. 9 We all know that sugar,makes ... or chewiness, and protects the safety of jams and ... brings to jams and jellies can,also help heal wounds?, ... creations. Many of the,same properties that make sugar an ...
Cached Medicine News:Health News:How do Lactobacilli treat Helicobacter pylori-related diseases? 2Health News:Texas Brain and Spine Institute to Hold Second Annual Neuroscience Symposium 2Health News:Genetic region linked to a 5 times higher lung cancer risk 2Health News:Genetic region linked to a 5 times higher lung cancer risk 3Health News:Blood Pressure Treatment Can Be Used Against Stroke 2Health News:Sugar's Healing Powers 2
... provides a versatile means of sectioning fresh ... The 1000 employs a vibrating blade principle ... The creation of artifacts, the alteration ... and other deleterious effects inherent in freezing ...
... The original Vibratome Semi-Automatic Tissue Sectioning ... rock solid tissue sectioning system. Researchers from ... Vibratome 1000 Classic for their fresh and ... 20 years. With the Vibratome ...
Replacement bulb for Vibratome light system....
Injector blades come ten to an injector and allow for the easy replacement of Vibratome cutting blades....
Medicine Products: